Efficacy and safety of testosterone treatment in postmenopausal female sexual interest and arousal disorder
European Gynecology & Obstetrics · 14.04.2026 · 8 (1)
DOI: 10.53260/ego.2680110 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Gynecology & Obstetrics, online erschienen am 14.04.2026. Verfasst von Patrícia Torné Castells und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Female sexual interest and arousal disorder (FSIAD) is the most prevalent sexual dysfunction in postmenopausal women.
Objective
To systematically review and summarize the existing evidence on the efficacy and safety of testosterone, mainly in transdermal formulations, for the treatment of FSIAD in postmenopausal women.
Method
A systematic review was conducted, including randomized controlled trials, systematic reviews, and meta-analyses. The eligibility of 105 articles was assessed, and 13 were ultimately included in the synthesis following the PRISMA procedure.
Results
Compared with placebo, testosterone was associated with significant improvements in the frequency of satisfactory sexual activity, orgasm, sexual desire, and personal distress related to low desire. Most adverse events were mild and well tolerated. No data indicated severe short-term adverse effects, although long-term safety data remain limited.
Conclusion
The short-term efficacy in improving sexual function and safety of testosterone (especially transdermal) in naturally or surgically menopausal women with FSIAD, either with or without estrogen +/- progestogen hormone therapy, has been demonstrated in this systematic review. Testosterone use was associated with an increase in androgenic adverse effects such as acne or hair growth, but was not associated with any serious adverse effects.
Zitieren
APA
Castells, P. T., & Castelo-Branco, C. (2026). Efficacy and safety of testosterone treatment in postmenopausal female sexual interest and arousal disorder. European Gynecology & Obstetrics, 8(1). https://doi.org/10.53260/ego.2680110
Vancouver
Castells PT, Castelo-Branco C. Efficacy and safety of testosterone treatment in postmenopausal female sexual interest and arousal disorder. European Gynecology & Obstetrics. 2026;8(1). doi:10.53260/ego.2680110
BibTeX
@article{Castells2026,
author = {Castells, Patrícia Torné and Castelo-Branco, Camil},
title = {Efficacy and safety of testosterone treatment in postmenopausal female sexual interest and arousal disorder},
journal = {European Gynecology & Obstetrics},
year = {2026},
volume = {8},
number = {1},
doi = {10.53260/ego.2680110}
}
EUVIMED